Literature DB >> 7632987

Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances.

M Terman1, A J Lewy, D J Dijk, Z Boulos, C I Eastman, S S Campbell.   

Abstract

Advanced and delayed sleep phase disorders, and the hypersomnia that can accompany winter depression, have been treated successfully by appropriately timed artificial bright light exposure. Under entrainment to the 24-h day-night cycle, the sleep-wake pattern may assume various phase relationships to the circadian pacemaker, as indexed, for example, by abnormally long or short intervals between the onset of melatonin production or the core body temperature minimum and wake-up time. Advanced and delayed sleep phase syndromes and non-24-h sleep-wake syndrome have been variously ascribed to abnormal intrinsic circadian periodicity, deficiency of the entrainment mechanism, or--most simply--patterns of daily light exposure insufficient for adequate phase resetting. The timing of sleep is influenced by underlying circadian phase, but psychosocial constraints also play a major role. Exposure to light early or late in the subjective night has been used therapeutically to produce corrective phase delays or advances, respectively, in both the sleep pattern and circadian rhythms. Supplemental light exposure in fall and winter can reduce the hypersomnia of winter depression, although the therapeutic effect may be less dependent on timing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632987     DOI: 10.1177/074873049501000206

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  15 in total

1.  [The current state of research in bright light therapy].

Authors:  Daniela Bassa; Markus Canazei; Hartmann Hinterhuber; Elisabeth M Weiss
Journal:  Neuropsychiatr       Date:  2013-06-21

Review 2.  Melatonin, sleep, aging, and the health protection branch.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  Effect of exposure duration and light spectra on nighttime melatonin suppression in adolescents and adults.

Authors:  R Nagare; B Plitnick; M G Figueiro
Journal:  Light Res Technol       Date:  2018-03-14

Review 4.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  The relationship between fatigue and light exposure during chemotherapy.

Authors:  Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Sherella Johnson; Mairav Cohen-Zion; Lavinia Fiorentino; Georgia Robins Sadler; Sonia Ancoli-Israel
Journal:  Support Care Cancer       Date:  2005-04-29       Impact factor: 3.603

6.  Fatigue and Circadian Activity Rhythms in Breast Cancer Patients Before and After Chemotherapy: A Controlled Study.

Authors:  Lianqi Liu; Michelle Rissling; Ariel Neikrug; Lavinia Fiorentino; Loki Natarajan; Michelle Faierman; Georgia Robins Sadler; Joel E Dimsdale; Paul J Mills; Barbara A Parker; Sonia Ancoli-Israel
Journal:  Fatigue       Date:  2013-01-24

7.  Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep.

Authors:  Horng-Shiuann Wu; F Gao; L Yan; C Given
Journal:  Chronobiol Int       Date:  2021-11-03       Impact factor: 2.877

8.  Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy.

Authors:  Neelum Jeste; Lianqi Liu; Michelle Rissling; Vera Trofimenko; Loki Natarajan; Barbara A Parker; Sonia Ancoli-Israel
Journal:  Qual Life Res       Date:  2012-08-03       Impact factor: 4.147

9.  Effect of Light on Human Circadian Physiology.

Authors:  Jeanne F Duffy; Charles A Czeisler
Journal:  Sleep Med Clin       Date:  2009-06

10.  Bright light shows promise in improving sleep, depression, and quality of life in women with breast cancer during chemotherapy: findings of a pilot study.

Authors:  Horng-Shiuann Wu; J E Davis; L Chen
Journal:  Chronobiol Int       Date:  2021-01-21       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.